p300 Regulates the Synergy of Steroidogenic Factor-1 and Early Growth Response-1 in Activating Luteinizing Hormone-β Subunit Gene
Jean–Francois Mouillet,Christina Sonnenberg-Hirche,Xiaomei Yan,Yoel Sadovsky
DOI: https://doi.org/10.1074/jbc.M312574200
IF: 5.485
2004-01-01
Journal of Biological Chemistry
Abstract:Tight regulation of luteinizing hormone-β subunit (LHβ) expression is critical for differentiation and maturation of mammalian sexual organs and reproductive function. Two transcription factors, steroidogenic factor-1 (SF-1) and early growth response-1 (Egr-1), play a central role in activating LHβ promoter, and the synergy between these two factors is essential in mediating gonadotropin-releasing hormone stimulation of LHβ promoter. Here we demonstrate that the transcriptional co-activator p300 regulates this synergy. Overexpression of p300 results in strong stimulation of LHβ promoter but only in the presence of both SF-1 and Egr-1, and not in the presence of other Egr proteins. Mutation of the binding sites for either SF-1 or Egr-1 completely abolishes the synergy between these two factors, as well as the influence of p300. Importantly, LHβ promoter is precipitated using p300 antibodies in a chromatin immunoprecipitation assay with LβT2 gonadotropes, and this effect is enhanced by gonadotropin-releasing hormone. The influence of p300 on LHβ promoter is potentiated by steroid receptor co-activator, as well as by E1A proteins, and attenuated by Smad nuclear interacting protein 1. Taken together, these results suggest that p300 is recruited to LHβ promoter where it coordinates the functional synergy between SF-1 and Egr-1. Tight regulation of luteinizing hormone-β subunit (LHβ) expression is critical for differentiation and maturation of mammalian sexual organs and reproductive function. Two transcription factors, steroidogenic factor-1 (SF-1) and early growth response-1 (Egr-1), play a central role in activating LHβ promoter, and the synergy between these two factors is essential in mediating gonadotropin-releasing hormone stimulation of LHβ promoter. Here we demonstrate that the transcriptional co-activator p300 regulates this synergy. Overexpression of p300 results in strong stimulation of LHβ promoter but only in the presence of both SF-1 and Egr-1, and not in the presence of other Egr proteins. Mutation of the binding sites for either SF-1 or Egr-1 completely abolishes the synergy between these two factors, as well as the influence of p300. Importantly, LHβ promoter is precipitated using p300 antibodies in a chromatin immunoprecipitation assay with LβT2 gonadotropes, and this effect is enhanced by gonadotropin-releasing hormone. The influence of p300 on LHβ promoter is potentiated by steroid receptor co-activator, as well as by E1A proteins, and attenuated by Smad nuclear interacting protein 1. Taken together, these results suggest that p300 is recruited to LHβ promoter where it coordinates the functional synergy between SF-1 and Egr-1. Reproductive development and function in mammals depends on exquisite regulation of luteinizing hormone (LH) 1The abbreviations used are: LH, luteinizing hormone; SF-1, steroidogenic factor-1; Egr, early growth response; GnRH, gonadotropin-releasing hormone; PPARγ, peroxisome proliferator-activated receptor-γ; SRC, steroid receptor co-activator; SNIP1, Smad nuclear interacting protein 1; ChIP, chromatin immunoprecipitation; CBP, cAMP-response element-binding protein-binding protein; RLU, relative luciferase units; ANOVA, analysis of variance. 1The abbreviations used are: LH, luteinizing hormone; SF-1, steroidogenic factor-1; Egr, early growth response; GnRH, gonadotropin-releasing hormone; PPARγ, peroxisome proliferator-activated receptor-γ; SRC, steroid receptor co-activator; SNIP1, Smad nuclear interacting protein 1; ChIP, chromatin immunoprecipitation; CBP, cAMP-response element-binding protein-binding protein; RLU, relative luciferase units; ANOVA, analysis of variance. release by anterior pituitary gonadotropes. Impaired fertility has been associated with underproduction, as well as overproduction, of LH (reviewed in Ref. 1Themmen A.P.N. Huhtaniemi I.T. Endocr. Rev. 2000; 21: 551-583Crossref PubMed Google Scholar). The secretion of LH is stimulated by pulsed release of the hypothalamic decapeptide gonadotropin-releasing hormone (GnRH), which also stimulates the synthesis and release of follicle-stimulating hormone. LH and follicle-stimulating hormone are heterodimeric glycoproteins that consist of a common α-subunit and a unique β-subunit (2Gharib S.D. Wierman M.E. Shupnik M.A. Chin W.W. Endocr. Rev. 1990; 11: 177-199Crossref PubMed Scopus (601) Google Scholar). Binding of GnRH to its membrane receptor (3Tsutsumi M. Zhou W. Millar R.P. Mellon P.L. Roberts J.L. Flanagan C.A. Dong K. Gillo B. Sealfon S.C. Mol. Endocrinol. 1992; 6: 1163-1169Crossref PubMed Scopus (218) Google Scholar) induces a cascade of phosphorylation signals that lead to the activation of LHβ promoter (reviewed in Ref. 4Kraus S. Naor Z. Seger R. Arch. Med. Res. 2001; 32: 499-509Crossref PubMed Scopus (151) Google Scholar).Several regulatory elements have been identified within 500 bp upstream of the transcription start site in LHβ gene. However, a sequence located within 150 bp upstream of the transcription start site can drive the expression of a reporter gene in the gonadotrope cell line LβT2 in response to GnRH treatment (5Dorn C. Ou Q. Svaren J. Crawford P.A. Sadovsky Y. J. Biol. Chem. 1999; 274: 13870-13876Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar). This small region contains two tandem SF-1/Egr-1 elements separated by a Pitx1 binding element. Indeed, these factors have been clearly shown to regulate LHβ gene transcription (5Dorn C. Ou Q. Svaren J. Crawford P.A. Sadovsky Y. J. Biol. Chem. 1999; 274: 13870-13876Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar, 6Halvorson L.M. Kaiser U.B. Chin W.W. J. Biol. Chem. 1996; 271: 6645-6650Abstract Full Text Full Text PDF PubMed Scopus (155) Google Scholar, 7Keri R.A. Wolfe M.W. Saunders T.L. Anderson I. Kendall S.K. Wagner T. Yeung J. Gorski J. Nett T.M. Camper S.A. Nilson J.H. Mol. Endocrinol. 1994; 8: 1807-1816Crossref PubMed Google Scholar, 8Lee S.L. Sadovsky Y. Swirnoff A.H. Polish J.A. Goda P. Gavrilina G. Milbrandt J. Science. 1996; 273: 1219-1221Crossref PubMed Scopus (434) Google Scholar, 9Tremblay J.J. Drouin J. Mol. Cell. Biol. 1999; 19: 2567-2576Crossref PubMed Google Scholar, 10Tremblay J.J. Marcil A. Gauthier Y. Drouin J. EMBO J. 1999; 18: 3431-3441Crossref PubMed Scopus (114) Google Scholar). In vivo, both SF-1 and Egr-1 play an essential role in the regulation of LHβ gene, as SF-1 knockout mice (11Luo X. Ikeda Y. Parker K.L. Cell. 1994; 77: 481-490Abstract Full Text PDF PubMed Scopus (1358) Google Scholar, 12Sadovsky Y. Crawford P. Woodson K. Polish J. Clements M. Tourtellotte L. Simburger K. Milbrandt J. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 10939-10943Crossref PubMed Scopus (384) Google Scholar, 13Zhao L. Bakke M. Krimkevich Y. Cushman L.J. Parlow A.F. Camper S.A. Parker K.L. Development. 2001; 128: 147-154PubMed Google Scholar) or Egr-1 knockout mice (8Lee S.L. Sadovsky Y. Swirnoff A.H. Polish J.A. Goda P. Gavrilina G. Milbrandt J. Science. 1996; 273: 1219-1221Crossref PubMed Scopus (434) Google Scholar, 14Topilko P. Schneider-Maunoury S. Levi G. Trembleau A. Gourdji D. Driancourt M.A. Rao C.V. Charnay P. Mol. Endocrinol. 1997; 12: 107-122Crossref Scopus (238) Google Scholar) exhibit a dramatic LHβ deficiency, resulting in abnormal development and infertility (15Hammer G.D. Ingraham H.A. Front. Neuroendocrinol. 1999; 20: 199-223Crossref PubMed Scopus (83) Google Scholar, 16Ingraham H.A. Lala D.S. Ikeda Y. Luo X. Shen W.H. Nachtigal M.W. Abbud R. Nilson J.H. Parker K.L. Genes Dev. 1994; 8: 2302-2312Crossref PubMed Scopus (510) Google Scholar). These two factors are not only obligatory for activation of LHβ promoter, but they also synergize with each other to activate LHβ promoter in a GnRH-dependent manner (5Dorn C. Ou Q. Svaren J. Crawford P.A. Sadovsky Y. J. Biol. Chem. 1999; 274: 13870-13876Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar, 8Lee S.L. Sadovsky Y. Swirnoff A.H. Polish J.A. Goda P. Gavrilina G. Milbrandt J. Science. 1996; 273: 1219-1221Crossref PubMed Scopus (434) Google Scholar, 17Halvorson L.M. Ito M. Jameson J.L. Chin W.W. J. Biol. Chem. 1998; 273: 14712-14720Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar). This synergistic interaction between SF-1 and Egr-1 has been observed using LHβ promoter from different species, supporting the notion that this conserved mechanism is relevant for precise regulation of LHβ gene expression (18Wolfe M.W. Call G.B. Mol. Endocrinol. 1999; 13: 752-763PubMed Google Scholar, 19Weck J. Anderson A.C. Jenkins S. Fallest P.C. Shupnik M.A. Mol. Endocrinol. 2000; 14: 472-485Crossref PubMed Google Scholar). Although paramount to regulation of LHβ gene, the mechanism of synergy between SF-1 and Egr-1 is not known (9Tremblay J.J. Drouin J. Mol. Cell. Biol. 1999; 19: 2567-2576Crossref PubMed Google Scholar, 17Halvorson L.M. Ito M. Jameson J.L. Chin W.W. J. Biol. Chem. 1998; 273: 14712-14720Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar). Notably, this synergy requires the binding of both SF-1 and Egr-1 to their respective LHβ promoter elements (5Dorn C. Ou Q. Svaren J. Crawford P.A. Sadovsky Y. J. Biol. Chem. 1999; 274: 13870-13876Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar). Direct interaction between SF-1 and Egr-1 has been detected in vitro using a pulldown experiment, but not using an electromobility shift assay (17Halvorson L.M. Ito M. Jameson J.L. Chin W.W. J. Biol. Chem. 1998; 273: 14712-14720Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar).The co-activator p300/CBP is known to regulate gene expression by bridging promoter-bound transcription factors with the basal transcriptional machinery (for review, see Ref. 20Shikama N. Lyon J. La Thangue N.B. Trends Cell Biol. 1997; 7: 230-236Abstract Full Text PDF PubMed Scopus (424) Google Scholar). Because SF-1 and Egr-1 can individually interact with the coactivator p300/CBP (21Monte D. DeWitte F. Hum D.W. J. Biol. Chem. 1998; 273: 4585-4591Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar, 22Silverman E.S. Du J. Williams A.J. Wadgaonkar R. Drazen J.M. Collins T. Biochem. J. 1998; 336: 183-189Crossref PubMed Scopus (96) Google Scholar) we postulated that SF-1 and Egr-1, bound to their cognate response elements, form a docking platform for p300, which, in turn, would enhance the recruitment of additional co-factors leading to enhanced LHβ transcription. We therefore tested the hypothesis that p300 influences the transcriptional activation of LHβ promoter by SF-1 and Egr-1.EXPERIMENTAL PROCEDURESPlasmids—The mammalian expression vectors for SF-1 (23Crawford P.A. Dorn C. Sadovsky Y. Milbrandt J. Mol. Cell. Biol. 1998; 18: 2949-2956Crossref PubMed Scopus (282) Google Scholar), Egr-1, Egr-2, Egr-3, and Egr-4 (5Dorn C. Ou Q. Svaren J. Crawford P.A. Sadovsky Y. J. Biol. Chem. 1999; 274: 13870-13876Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar, 24Russo M.W. Matheny C. Milbrandt J. Mol. Cell. Biol. 1993; 13: 6858-6865Crossref PubMed Scopus (88) Google Scholar), p300-HA, p300del30-HA (25Eckner R. Ewen M.E. Newsome D. Gerdes M. DeCaprio J.A. Lawrence J.B. Livingston D.M. Genes Dev. 1994; 8: 869-884Crossref PubMed Scopus (920) Google Scholar), p300 (1514–1922) (26Yuan W. Condorelli G. Caruso M. Felsani A. Giordano A. J. Biol. Chem. 1996; 271: 9009-9013Abstract Full Text Full Text PDF PubMed Scopus (275) Google Scholar), E1A 12S, E1A 13S (27Morris G.F. Mathews M.B. J. Virol. 1991; 65: 6397-6406Crossref PubMed Google Scholar), SRC-1 (28Crawford P.A. Polish J.A. Ganpule G. Sadovsky Y. Mol. Endocrinol. 1997; 11: 1626-1635Crossref PubMed Scopus (92) Google Scholar), SRC-2/TIF2 (29Voegel J.J. Heine M.J. Zechel C. Chambon P. Gronemeyer H. EMBO J. 1996; 15: 3667-3675Crossref PubMed Scopus (947) Google Scholar), SRC-3/ACTR (30Chen H. Lin R.J. Schiltz R.L. Chakravarti D. Nash A. Nagy L. Privalsky M.L. Nakatani Y. Evans R.M. Cell. 1997; 90: 569-580Abstract Full Text Full Text PDF PubMed Scopus (1253) Google Scholar), and SNIP1 (31Kim R.H. Wang D. Tsang M. Martin J. Huff C. de Caestecker M.P. Parks W.T. Meng X. Lechleider R.J. Wang T. Roberts A.B. Genes Dev. 2000; 14: 1605-1616PubMed Google Scholar) have been described previously. The wild type and mutant -156 to +7 LHβ promoter constructs have been described (5Dorn C. Ou Q. Svaren J. Crawford P.A. Sadovsky Y. J. Biol. Chem. 1999; 274: 13870-13876Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar).Cell Culture and Transfections—CV-1 and 293 cells were maintained in Dulbecco's modified Eagle's medium, with 10% fetal bovine serum and antibiotics at 37 °C at 10 and 5% CO2, respectively. JEG3 cells were grown in minimum essential medium with 10% fetal bovine serum and antibiotics at 5% CO2. LβT2 cells, obtained from Pamela Mellon (University of California, San Diego, CA), were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and were cultured in a 5% CO2 environment (32Alarid E.T. Windle J.J. Whyte D.B. Mellon P.L. Development. 1996; 122: 3319-3329PubMed Google Scholar, 33Turgeon J.L. Kimura Y. Waring D.W. Mellon P. Mol. Endocrinol. 1996; 10: 439-450Crossref PubMed Google Scholar). GnRH (100 nm) was added to plated cells 24, 6, and 1 h before harvest. CV1, JEG3, and 293 cells were transfected using the modified calcium phosphate method described previously (34Chen C. Okayama H. Mol. Cell. Biol. 1987; 7: 2745-2752Crossref PubMed Scopus (4809) Google Scholar, 35Ou Q. Mouillet J.F. Yan X. Dorn C. Crawford P.A. Sadovsky Y. Mol. Endocrinol. 2001; 15: 69-79Crossref PubMed Scopus (75) Google Scholar). LβT2 cells were transfected using FuGENE 6 (Roche Applied Science), following the manufacturer's protocol. Empty expression plasmids were used to balance the total amount of transfected DNA, where necessary. Standard luciferase assays were performed 48 h after transfection as described previously (28Crawford P.A. Polish J.A. Ganpule G. Sadovsky Y. Mol. Endocrinol. 1997; 11: 1626-1635Crossref PubMed Scopus (92) Google Scholar), using a Lumistar 96-well plate reader (BMG, Durham, NC). Because we found that p300 influenced the expression of the control vector β-galactosidase, we normalized the results to transfection efficiency and cell viability by one of the following methods: (1) determination of total protein in transfected cells, and (2) Renilla luciferase activity, co-transfected using the pRL-null vector (Promega, Madison, WI) and determined by a dual-luciferase assay kit (Promega). Results were expressed as relative luciferase units (RLU). All experiments were performed in duplicate and repeated at least three times.Chromatin Immunoprecipitation and PCR—Approximately 1 × 107 LβT2 cells were grown on 10-cm dishes and cross-linked with 1% formaldehyde at room temperature for 15 min. The reaction was stopped by the addition of glycine to a final concentration of 0.125 m. Cells were scraped in phosphate-buffered saline, collected by centrifugation, and incubated for 10 min on ice in 200 μl of lysis buffer (50 mm Tris, pH 8.1, 10 mm EDTA, 1% SDS plus protease inhibitor mixture; Sigma). Cell lysates were then sonicated on ice to a mean length of 500–1,000 bp and then centrifuged at 14,000 rpm. The chromatin solution was diluted in a buffer containing 0.01% SDS, 1.1% Triton X-100, 1.2 nm EDTA, 16.7 mm Tris, pH 8.1, 167 mm NaCl and then pre-cleared with 80 μl of salmon sperm DNA/protein A-agarose slurry for 30 min at 4 °C with agitation. Input samples were obtained at 0.1% (v/v), followed by immunoprecipitation with specific antibodies at 4 °C overnight. The antibodies included anti-p300 (sc584), anti-Egr-1 (sc110), and anti-PPARγ (sc1984), all from Santa Cruz Biotechnology, Inc., and anti-SF-1 (06–431) from Upstate Biotechnology. Immune complexes were collected with 60 μl of salmon sperm DNA/protein A-agarose slurry and sequentially washed for 10 min each in low salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mm EDTA, 20 mm Tris, pH 8.1, 150 mm NaCl), high salt buffer (0.1% SDS, 1% Triton X-100, 2 mm EDTA, 20 mm Tris, pH 8.1, 500 mm NaCl), LiCl wash buffer (0.25 m LiCl, 15 Nonidet P-40, 1% deoxycholate, 1 mm EDTA, 10 mm Tris, pH 8.1), and two washes with Tris/EDTA buffer. Precipitates were then extracted two times with 1% SDS, 0.1 m NaCO3. Eluates were pooled, and cross-linking was reversed by incubation at 65 °C overnight. Samples were then digested with proteinase K (Roche Diagnostics) for 2 h at 45 °C and purified by phenol-chloroform extraction followed by ethanol precipitation. The DNA was dissolved in 50 μl of Tris/EDTA buffer, and 5 μl was used for PCR, described below.For standard PCR, immunoprecipitated DNA was used as a template in 25-μl reactions using specific LHβ promoter primers, which include forward primer 5′-TTCAGCGAGCAGCCTGCAGTGGCCTCCCCT and reverse primer 5′-CCACTAAGTAGTGGCTACAGGCTTGGGTAA. Band density was quantified using LabWorks 4.0 software (UVP, Upland, CA). Transcript level was determined by quantitative PCR using a 5700 Sequence Detector System (Applied Biosystems). Each 50 μl of PCR included 3 μl of reverse transcription products, forward primers (5′-GGTTACCCAAGCCTGTAGCCA) and reverse primers (5′-TGGCTTTATACCTGCGGGTT), and 25 μl of SYBER Green Master mix (Applied Biosystems). Transcript level was determined by using Gene-Amp 5700 SDS software (Applied Biosystems).Statistics—Each set of results was determined in duplicate and repeated at least three times. Because of the nature of transfection experiments, representative results are shown. For chromatin immunoprecipitation (ChIP) experiments, data presented are mean ± S.D. from four independent experiments. Relevant paradigms were compared using analysis of variance (ANOVA), with post hoc Bonferroni t test (Primers of Biostatistics, v. 3.0). A value of p < 0.05 was determined significant.RESULTSP300 Strongly Stimulates the Activity of LHβ Promoter—To test the hypothesis that p300 influences the transcriptional activation of LHβ promoter by SF-1 and Egr-1 we initially determined the effect of p300 on the activity of LHβ promoter. For this purpose, we transiently transfected CV1 cells with expression plasmids for SF-1, Egr-1, and p300, along with an LHβ reporter construct that spans nucleotides -156 to +7 of rat LHβ promoter upstream of luciferase. As shown in Fig. 1, in the absence of SF-1 and Egr-1 (lane 2) we observed minimal and non-significant activation of LHβ promoter by p300. The influence of p300 on LHβ promoter was pronounced in the presence of either SF-1 or Egr-1 (Fig. 1, lanes 5 and 8). Coexpression of SF-1 and Egr-1, along with p300, resulted in dramatic up-regulation of LHβ promoter (Fig. 1, compare lane 11 with lanes 5 and 8), suggesting that p300 potentiates the synergy between SF-1 and Egr-1 in regulation of LHβ promoter. As a control we tested the effect of steroid receptor co-activator-1 (SRC-1), a co-activator known to interact with and enhance the transcriptional activity of SF-1 (28Crawford P.A. Polish J.A. Ganpule G. Sadovsky Y. Mol. Endocrinol. 1997; 11: 1626-1635Crossref PubMed Scopus (92) Google Scholar, 36Ito M. Yu R.N. Jameson J.L. Mol. Endocrinol. 1998; 12: 290-301Crossref PubMed Scopus (123) Google Scholar). As expected, SRC-1 potentiated the interaction of SF-1 and Egr-1 on LHβ promoter (Fig. 1, lane 12), but to a lesser extent than p300. To ensure that these results are not cell type-specific we repeated these experiments in JEG3 cells, as well as 293 cells, and recapitulated in these cell lines the strong p300-dependent potentiation of LHβ promoter transactivation by SF-1/Egr-1 synergy (not shown). To ensure that the dramatic p300-dependent increase in LHβ reporter activity is not because of significant alteration of SF-1 and Egr-1 expression we examined the level of these factors in transfected cells, using Western analysis. We found that the level of transfected SF-1, but not Egr-1, is weakly (3–5-fold) increased in the presence of overexpressed p300 (not shown). Moreover, transfection of 10-fold more SF-1 expression plasmid alone resulted in only a minor increase of the LHβ promoter activity compared with the combined effect of SF-1/Egr-1 with p300, effectively ruling out altered SF-1/Egr-1 expression level as an explanation for the striking effect of p300.To obtain further support for the influence of p300 on SF-1/Egr-1 synergy in the context of LHβ promoter we used LHβ promoter reporter plasmids that harbor mutated binding elements for Egr-1, SF-1, or both (5Dorn C. Ou Q. Svaren J. Crawford P.A. Sadovsky Y. J. Biol. Chem. 1999; 274: 13870-13876Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar). As shown in Fig. 2, mutations in either SF-1 or Egr-1 elements resulted in a dramatic reduction in SF-1/Egr-1 synergy and markedly attenuated the influence of p300 on LHβ promoter. These results demonstrate that p300 acts through interaction with DNA-bound SF-1 and Egr-1 in the context of LHβ promoter. Whereas SF-1 and Egr-1 may directly interact (9Tremblay J.J. Drouin J. Mol. Cell. Biol. 1999; 19: 2567-2576Crossref PubMed Google Scholar, 17Halvorson L.M. Ito M. Jameson J.L. Chin W.W. J. Biol. Chem. 1998; 273: 14712-14720Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar), our results suggest that this direct interaction is not sufficient for promoter potentiation by p300, which requires tethering of SF-1 and Egr-1 to their promoter elements.Fig. 2The stimulation of LHβ promoter by p300 requires binding of both SF-1 and Egr-1 to their promoter elements. Binding elements for SF-1 and Egr-1 in LHβ promoter are shown. CV-1 cells were transiently transfected with wild type or mutated forms of the rat LHβ-luciferase construct, along with SF-1 (0.1 μg), Egr-1 (0.4 μg), and p300 (3.0 μg). The total amount of transfected DNA was kept equal by addition of empty expression plasmids. Luciferase activity was measured 48 h after transfection. Results (mean ± S.D.) are expressed as RLU and represent three independent experiments, each performed in duplicate. The effect of p300 on each promoter construct except for LHβ mutated in all four sites was significant (ANOVA; p < 0.001, with post hoc Bonferroni t test p < 0.05).View Large Image Figure ViewerDownload Hi-res image Download (PPT)The murine gonadotrope cell line LβT2 expresses LHα and LHβ (32Alarid E.T. Windle J.J. Whyte D.B. Mellon P.L. Development. 1996; 122: 3319-3329PubMed Google Scholar, 37Alarid E.T. Holley S. Hayakawa M. Mellon P.L. Mol. Cell. Endocrinol. 1998; 140: 25-30Crossref PubMed Scopus (32) Google Scholar), as well as SF-1 and Egr-1, and up-regulates LH secretion by GnRH stimulation (5Dorn C. Ou Q. Svaren J. Crawford P.A. Sadovsky Y. J. Biol. Chem. 1999; 274: 13870-13876Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar, 32Alarid E.T. Windle J.J. Whyte D.B. Mellon P.L. Development. 1996; 122: 3319-3329PubMed Google Scholar, 33Turgeon J.L. Kimura Y. Waring D.W. Mellon P. Mol. Endocrinol. 1996; 10: 439-450Crossref PubMed Google Scholar, 38Thomas P. Mellon P.L. Turgeon J.L. Waring D.W. Endocrinology. 1996; 137: 2979-2980Crossref PubMed Scopus (124) Google Scholar). We therefore sought to confirm the influence of p300 on LHβ in these cells. We transiently transfected LβT2 cells with p300, along with our LHβ-promoter reporter gene. As shown in Fig. 3, we found that overexpression of p300 in LβT2 cells led to a significant up-regulation of basal LHβ reporter. This effect was further potentiated by exposing LβT2 cells to GnRH, thus providing further support to the influence of p300 on LHβ activation by SF-1 and Egr-1.Fig. 3p300 enhances transactivation by SF-1 and Egr-1 in LβT2 cells. LβT2 cells were transiently transfected with the rat LHβ-luciferase construct, along with SF-1 (0.1 μg), Egr-1 (0.4 μg), and increasing amounts of p300. The total amount of transfected DNA was kept equal by addition of empty expression plasmids. Cells were stimulated for 24, 6, and 1 h with GnRH (100 mm) before harvest. Luciferase activity was measured 48 h after transfection. Results (mean ± S.D.) are expressed as RLU and represent three independent experiments, each performed in duplicate. The effect of each p300 concentration versus control, in the presence or absence of GnRH, was significant (ANOVA; p < 0.04, with post hoc Bonferroni t test p < 0.05).View Large Image Figure ViewerDownload Hi-res image Download (PPT)LHβ Promoter Occupancy in LβT2 Cells—Having shown that p300 acts as a co-activator for SF-1/Egr-1 in transfected cells, we utilized ChIP to determine whether p300 is physically recruited to LHβ promoter. We performed these experiments in LβT2 cells, which produce LHβ and in which p300 overexpression was shown to significantly enhance a LHβ reporter. LβT2 cells were treated with 1% formaldehyde to cross-link proteins to chromatin within the live cells, and complexes were captured using specific antibodies. To confirm the specificity of our immunoprecipitation we performed parallel experiments with a protein A-agarose mixture that either lacked the relevant antibody or had been bound to an irrelevant antibody (nonspecific IgG or anti-PPARγ antibody). As shown in Fig. 4A, the use of p300 antibody resulted in enrichment of the DNA genomic segment harboring LHβ promoter, confirming the recruitment of this factor to the promoter. As positive control we used anti-SF-1 or -Egr-1 antibodies, both resulting in precipitation of the genomic LHβ promoter fragment. In contrast, there was no precipitation using a control, nonspecific IgG (Fig. 4A) or anti-PPARγ antibody (not shown).Fig. 4Recruitment of p300, SF-1, and Egr-1 to LHβ promoter. The direct interaction of p300, Egr-1, and SF-1 with the endogenous LHβ promoter was determined by ChIP analysis in LβT2 cells. Cells were treated with formaldehyde, washed, lysed, and sonicated. The DNA-protein complexes were immunoprecipitated with indicated antibodies and captured with protein A-agarose beads. The DNA was purified and amplified with primers flanking LHβ promoter. Input DNA represents a fraction of the sonicated chromatin prior to immunoprecipitation. A, chromatin preparations from untreated cells were immunoprecipitated with p300, Egr-1, or SF-1 antibodies, and precipitated DNA was subjected to 30 cycles of PCR. Amplification products were visualized with ethidium bromide staining. Rabbit nonimmune IgG (or anti PPARγ antibodies; not shown) was included as a negative control. B, LβT2 cells were stimulated with or without GnRH (10-7m), and immunoprecipitated DNA was amplified using PCR. Densitometric analysis of the bands is shown below the figure, demonstrating the influence of GnRH on precipitation of p300, Egr-1, or SF-1. C, chromatin immunoprecipitation was quantitated by real-time PCR, as described under “Experimental Procedures.” The results depict mean ± S.D., derived from four independent experiments, expressed as -fold from GnRH-stimulated cells over non-stimulated cells for each antibody used in immunoprecipitation. Control immunoprecipitation with IgG was arbitrarily defined as one. * denotes p < 0.05 compared with IgG control (ANOVA, with post hoc Bonferroni t test).View Large Image Figure ViewerDownload Hi-res image Download (PPT)Because we have demonstrated previously that GnRH enhances the functional interaction of SF-1 and Egr-1, we assessed the influence of GnRH on the recruitment of p300 to LHβ promoter. Using qualitative PCR in four independent ChIP experiments we consistently found an increase in PCR-amplified DNA from chromatin complexes precipitated with p300 in GnRH-stimulated LβT2, compared with non-stimulated cells (Fig. 4B). Similar results were found with precipitation of Egr-1, but not SF-1. To quantify the changes in immunoprecipitated chromatin, we used real time quantitative PCR. As shown in Fig. 4C, a significant influence of GnRH was observed on precipitation of LHβ chromatin fragment with p300 antibody. We also confirmed the qualitative PCR data, demonstrating a significant influence of GnRH on precipitation of LHβ promoter fragment using anti Egr-1 antibodies. As expected, the effect of GnRH on SF-1 was not significant. Together, these results indicate that p300 is physically recruited to endogenous LHβ promoter in LβT2 cells and that this recruitment is enhanced following stimulation by GnRH.p300 Potentiates the Effect of SRC/p160 Co-activators on LHβ Promoter—SF-1 has been shown to interact with all three members of the p160 steroid receptor co-activator family of proteins, SRC-1 (28Crawford P.A. Polish J.A. Ganpule G. Sadovsky Y. Mol. Endocrinol. 1997; 11: 1626-1635Crossref PubMed Scopus (92) Google Scholar, 36Ito M. Yu R.N. Jameson J.L. Mol. Endocrinol. 1998; 12: 290-301Crossref PubMed Scopus (123) Google Scholar), SRC-2/GRIP1/TIF2 (29Voegel J.J. Heine M.J. Zechel C. Chambon P. Gronemeyer H. EMBO J. 1996; 15: 3667-3675Crossref PubMed Scopus (947) Google Scholar, 39Hong H. Kohli K. Trivedi A. Johnson D.L. Stallcup M.R. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 4948-4952Crossref PubMed Scopus (611) Google Scholar), and SRC-3/p/CIP/AIB1/ACTR/RAC3/TRAM-1 (30Chen H. Lin R.J. Schiltz R.L. Chakravarti D. Nash A. Nagy L. Privalsky M.L. Nakatani Y. Evans R.M. Cell. 1997; 90: 569-580Abstract Full Text Full Text PDF PubMed Scopus (1253) Google Scholar, 40Torchia J. Rose D.W. Inostroza J. Kamei Y. Westin S. Glass C.K. Rosenfeld M.G. Nature.